Roles of Fascin mRNA expression in colorectal cancer: Meta‑analysis and bioinformatics analysis

Shi,Shuai; Zheng,Hua‑Chuan; Zhang,Zhi‑Gang

doi:10.3892/mco.2020.2069

Roles of Fascin mRNA expression in colorectal cancer: Meta‑analysis and bioinformatics analysis

Authors:
- Shuai Shi
- Hua‑Chuan Zheng
- Zhi‑Gang Zhang
View Affiliations

Affiliations: Department of Pathology, Cangzhou People's Hospital, Cangzhou, Hebei 061000, P.R. China
Published online on: June 11, 2020 https://doi.org/10.3892/mco.2020.2069
Pages: 119-128
Copyright: © Shi et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Fascin (encoded by FSCN1) is a globular actin cross-linking protein that is required for the formation of actin‑based cell surface processes, which are critical for cell migration and cell‑matrix adhesion. In the present study, a systematic meta‑analysis and bioinformatics analysis was used to identify clinicopathological or prognostic parameters in patients with colorectal cancer. A total of 17 articles were included in the present study obtained from PubMed, Web of Science, Wanfang data, SinoMed and CNKI databases. Odd ratios (ORs) and the corresponding 95% confidence intervals (CIs) were used to estimate the prognostic significance of Fascin expression in patients with colorectal cancer, and the association between Fascin expression and clinicopathological factors. There was a significant correlation between high Fascin expression and poor overall survival rates in patients with colorectal cancer (OR=0.48; 95% CI, 0.38‑0.60; P<0.000001). The meta‑analysis showed that the expression of Fascin was significantly higher in colorectal cancer tissue compared with the normal mucosa (OR=0.13; 95% CI, 0.10‑0.16; P<0.000001) and adenoma (OR=0.23; 95% CI, 0.15‑0.34; P<0.000001). Fascin expression was also associated with depth of invasion (OR=0.31; 95% CI, 0.19‑0.50; P<0.000001), lymph node metastasis (OR=3.07; 95% CI, 1.72‑5.46; P=0.0001), Dukes stage (OR=0.14; 95% CI, 0.04‑0.46; P=0.001), Tumor‑Node‑Metastasis stage (OR=0.38; 95% CI, 0.21‑0.71; P=0.003) and dedifferentiation (OR=0.42; 95% CI, 0.19‑0.94; P=0.04). According to the bioinformatics analyses, FSCN1 mRNA expression levels were higher in colorectal cancer and adenoma tissues compared with the normal tissues (P<0.05). According to TCGA, FSCN1 mRNA expression was associated with a less favorable prognosis in patients with colorectal cancer as an independent factor (P<0.05), and positively correlated with depth of invasion, microsatellite instability and low serum carcinoembryonic antigen levels in colorectal cancer. Taken together, the results of the present study suggested that Fascin expression is a potential marker of tumorigenesis, aggressiveness and poor prognosis in patients with colorectal cancer.

View Figures

View References

1	Li LJ, Xu L and Xia D: Progress of Fascin in colorectal cancer. J Mil Surg Southwest China. 14:753–756. 2012.PubMed/NCBI View Article : Google Scholar
2	Zhou C and Li TY: Research progress of the relationship between fascin protein and tumor. J Nanchang Univ (Medical Sciences). 53:94–96. 2013.
3	Hashimoto Y, Kim DJ and Adams JC: The roles of fascins in health and disease. J Pathol. 224:289–300. 2011.PubMed/NCBI View Article : Google Scholar
4	Swierczynski SL, Maitra A, Abraham SC, Iacobuzio-Donahue CA, Ashfaq R, Cameron JL, Schulick RD, Yeo CJ, Rahman A, Hinkle DA, et al: Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays. Hum Pathol. 35:357–366. 2004.PubMed/NCBI View Article : Google Scholar
5	Buda A and Pignatelli M: Cytoskeletal network in colon cancer: From genes to clinical application. Int J Biochem Cell Biol. 36:759–765. 2004.PubMed/NCBI View Article : Google Scholar
6	Tsai WC, Chao YC, Sheu LF, Chang JL, Nieh S and Jin JS: Overexpression of fascin-1 in advanced colorectal adenocarcinoma: Tissue microarray analysis of immunostaining scores with clinicopathological parameters. Dis Markers. 23:153–160. 2007.PubMed/NCBI View Article : Google Scholar
7	Uyama N, Iimuro Y, Kawada N, Reynaert H, Suzumura K, Hirano T, Kuroda N and Fujimoto J: Fascin, a novel marker of human hepatic stellate cells, may regulate their proliferation, migration, and collagen gene expression through the FAK-PI3K pathway. Lab Invest. 92:57–71. 2012.PubMed/NCBI View Article : Google Scholar
8	Gungor-Ordueri NE, Celik-Ozenci C and Cheng CY: Fascin 1 is an actin filament-bundling protein that regulates ectoplasmic specialization dynamics in the rat testis. Am J Physiol Endocrinol Metab. 307:E738–E753. 2014.PubMed/NCBI View Article : Google Scholar
9	Snyder M, Huang XY and Zhang JJ: Signal transducers and activators of transcription 3 (STAT3) directly regulates cytokine-induced fascin expression and is required for breast cancer cell migration. J Biol Chem. 286:38886–38893. 2011.PubMed/NCBI View Article : Google Scholar
10	Huang H, Zhao W and Yang D: Stat3 induces oncogenic Skp2 expression in human cervical carcinoma cells. Biochem Biophys Res Commun. 418:186–190. 2012.PubMed/NCBI View Article : Google Scholar
11	Wang J, Li X, Liu X and Pi L: The regulation of stat3 signal transduction pathway to G1 to S phase of laryngocarcinoma cell. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 22:699–703. 2008.(In Chinese). PubMed/NCBI
12	Zhang N, Shen Y and Hu G: Expression of fascin protein in human lung cancer and its clinical significance. J Nanjing Med Univ (Natural Sciences). 30:309–311. 2010.
13	Chen G, Zhang FR, Ren J, Tao LH, Shen ZY, Lv Z, Yu SJ, Dong BF, Xu LY and Li EM: Expression of fascin in thyroid neoplasms: A novel diagnostic marker. J Cancer Res Clin Oncol. 134:947–951. 2008.PubMed/NCBI View Article : Google Scholar
14	Kostopoulou E, Daponte A, Terzis A, Nakou M, Chiotoglou I, Theodosiou D, Chatzichristodoulou C, Messinis IE and Koukoulis G: Fascin in ovarian epithelial tumors. Histol Histopathol. 23:935–944. 2008.PubMed/NCBI View Article : Google Scholar
15	Iguchi T, Aishima S, Umeda K, Sanefuji K, Fujita N, Sugimachi K, Gion T, Taketomi A, Maehara Y and Tsuneyoshi M: Fascin expression in progression and prognosis of hepatocellular carcinoma. J Surg Oncol. 100:575–579. 2009.PubMed/NCBI View Article : Google Scholar
16	Kostopoulou E, Daponte A, Terzis A, Nakou M, Chiotoglou I, Theodosiou D, Chatzichristodoulou C, Messinis IE and Koukoulis G: Fascin in ovarian epithelial tumors. Histol Histopathol. 23:935–944. 2008.PubMed/NCBI View Article : Google Scholar
17	Gao X and Wu DH: Expression of FSCN1 protein in human epithelial tumor and its clinical significance. Nan Fang Yi Ke Da Xue Xue Bao. 28:953–955. 2008.(In Chinese).
18	Yamashiro S, Yamakita Y, Ono S and Matsumura F: Fascin, an actin-bundling protein, induces membrane protrusions and increases cell motility of epithelial cells. Mol Biol Cell. 9:993–1006. 1998.PubMed/NCBI View Article : Google Scholar
19	Xing P, Li JG, Jin F, Zhao TT, Liu Q, Dong HT and Wei XL: Fascin, an actin-bundling protein, promotes breast cancer progression in vitro. Cell Biochem Funct. 29:303–310. 2011.PubMed/NCBI View Article : Google Scholar
20	Vignjevic D, Schoumacher M, Gavert N, Janssen KP, Jih G, Laé M, Louvard D, Ben-Ze'ev A and Robine S: Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer. Cancer Res. 67:6844–6853. 2007.PubMed/NCBI View Article : Google Scholar
21	Hayashi Y, Toda K, Saibara T, Okamoto S, Osanai M, Enzan H and Lee GH: Expression of fascin-1, an actin-bundling protein, in migrating hepatoblasts during rat developmentliver. Cell Tissue Res. 334:219–226. 2008.PubMed/NCBI View Article : Google Scholar
22	Pang QH, Dai XL, Wu WX and Zhang HX: Expression of fascin and CXCR4 in colorectal carcinoma tissues and their clinical significance. Chin J Cancer Prev Treat. 18:1175–1185. 2011.
23	Kong FL, Hu LX, Li CF, Huang MQ, Jiang YJ, Liao HW, Wu Y and Wang FX: The expression of fascin-1 in colorectal cancer and its clinical significance. Chongqing Yixue. 45:1519–1521. 2016.
24	Li C, Cai L, Zhang N and Zhang RQ: Expression and significance of fascin-1 in colorectal adenoma and colorectal carcinoma. Health Magazine. 9:11–12. 2015.
25	Liu L and Ding YQ: Expression of fascin-1 in human colorectal cancer and its significance. J Fourth MiI Med Univ. 28:108–110. 2007.
26	Ding Y, Liu L, Jiang HY and Ding YQ: Expression and significance of Tiam1, fascin-1, and HSPB1 in human colorectal cancer. Guangdong Med J. 29:230–232. 2008.
27	Li HW, Wang TS, Huang Y, Li YH and Hu HX: Expression of fascin-1 protein in colorectal adenocarcinoma and relation with clinicopathologic characteristics. Chin J Bas Clin Gen Surg. 17:362–364. 2010.
28	Xue LY, Zou SM, Zheng S, Xie YQ, Wen F, Liu XY, Lin DM and Lü N: Expression of fascin and CK14 in different histological types of cancer and its differential diagnostic significance. Zhonghua Zhong Liu Za Zhi. 32:838–844. 2010.(In Chinese). PubMed/NCBI
29	Chan C, Jankova L, Fung CL, Clarke C, Robertson G, Chapuis PH, Bokey L, Lin BP, Dent OF and Clarke S: Fascin expression predicts survival after potentially curative resection of node-positive colon cancer. Am J Surg Pathol. 34:656–666. 2010.PubMed/NCBI View Article : Google Scholar
30	Yao DY, Zhang HY and Xu X: Expression of fascin in colorectal carcinoma and its correlation with prognosis. Hainan Med J. 25:3089–3091. 2014.
31	Zhao ZY: Expression and significance of fascin and iNOS in colorectal adenoma carcinogenesis. Medicine People. 7(66)2014.
32	Song XX: Expression and significance of fascin in canceration of colorectal adenoma. Heibei Med J. 32:2370–2372. 2010.
33	Yang Q, Lu ZH, Luo YF, Wan JW, Cao JL, Gao J, Wu SF and Chen J: Significance of fascin expression in colorectal adenoma and carcinoma. Chin J Diagn Pathol. 13:359–361. 2006.
34	Yi LJ: Expression and significance of fascin and P27 in colorectal carcinoma. Luzhou Medical College, 2013.
35	Oh SY, Kim YB, Suh KW, Paek OJ and Moon HY: Prognostic impact of fascin-1 expression is more significant in advanced colorectal cancer. J Surg Res. 172:102–108. 2012.PubMed/NCBI View Article : Google Scholar
36	Jung EJ, Lee JH, Min BW, Kim YS and Choi JS: Clinicopathologic significance of fascin, extracellular matrix metalloproteinase inducer, and ezrin expressions in colorectal adenocarcinoma. Indian J Pathol Microbiol. 54:32–36. 2011.PubMed/NCBI View Article : Google Scholar
37	Duh FM, Latif F, Weng Y, Geil L, Modi W, Stackhouse T, Matsumura F, Duan DR, Linehan WM, Lerman MI, et al: cDNA cloning and expression of the human homolog of the sea urchin fascin and Drosophila singed genes which encodes an actin-bundling protein. DNA Cell Biol. 13:821–827. 1994.PubMed/NCBI View Article : Google Scholar
38	Tubb BE, Bardien-Kruger S, Kashork CD, Shaffer LG, Ramagli LS, Xu JP, Siciliano MJ and Bryan J: Characterization of human retinal fascin gene (FSCN2) at 17q25: Close physical linkage of fascin and cytoplasmic actin genes. Genomics. 65:146–156. 2000.PubMed/NCBI View Article : Google Scholar
39	Tubb B, Mulholland DJ, Vogl W, Lan ZJ, Niederberger C, Cooney A and Bryan J: Testis fascin (FSCN3): A novel paralog of the actin-bundling protein fascin expressed specifically in the elongate spermatid head. Exp Cell Res. 275:92–109. 2002.PubMed/NCBI View Article : Google Scholar
40	Jawhari AU, Buda A, Jenkins M, Shehzad K, Sarraf C, Noda M, Farthing MJ, Pignatelli M and Adams JC: Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro. Am J Pathol. 162:69–80. 2003.PubMed/NCBI View Article : Google Scholar
41	Mosialos G, Birkenbach M, Ayehunie S, Matsumura F, Pinkus GS, Kieff E and Langhoff E: Circulating human dendritic cells differentially express high levels of a 55-kd actin-bundling protein. Am J Pathol. 148:593–600. 1996.PubMed/NCBI
42	Grothey A, Hashizume R, Sahin AA and Mccrea PD: Fascin, an actin-bundling protein associated with cell motility, is upregulated in hormone receptor negative breast cancer. Br J Cancer. 83:870–873. 2000.PubMed/NCBI View Article : Google Scholar
43	Roma AA and Prayson RA: Fascin expression in 90 patients with glioblastoma multiforme. Ann Diagn Pathol. 9:307–311. 2005.PubMed/NCBI View Article : Google Scholar
44	Xie JJ, Xu LY, Zhang HH, Cai WJ, Mai RQ, Xie YM, Yang ZM, Niu YD, Shen ZY and Li EM: Role of fascin in the proliferation and invasiveness of esophageal carcinoma cells. Biochem Biophys Res Commun. 337:355–362. 2005.PubMed/NCBI View Article : Google Scholar
45	Hashimoto Y, Shimada Y, Kawamura J, Yamasaki S and Imamura M: The prognostic relevance of fascin expression in human gastric carcinoma. Oncology. 67:262–270. 2004.PubMed/NCBI View Article : Google Scholar
46	Pelosi G, Pastorino U, Pasini F, Maissoneuve P, Fraggetta F, Iannucci A, Sonzogni A, De Manzoni G, Terzi A, Durante E, et al: Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer. Br J Cancer. 88:537–547. 2003.PubMed/NCBI View Article : Google Scholar
47	Tong GX, Yee H, Chiriboga L, Hernandez O and Waisman J: Fascin-1 expression in papillary and invasive urothelial carcinomas of the urinary bladder. Hum Pathol. 36:741–746. 2005.PubMed/NCBI View Article : Google Scholar
48	Fan G, Kotylo P, Neiman RS and Braziei RM: Comparison of fascin expression in anaplastic large cell lymphoma and Hodgkin disease. Am J Clin Pathol. 119:199–204. 2003.PubMed/NCBI View Article : Google Scholar
49	Hashimoto Y, Skacel M and Adams JC: Roles of fascin in human carcinoma motility and signaling: Prospects for a novel biomarker? Int J Biochem Cell Biol. 37:1787–1804. 2005.PubMed/NCBI View Article : Google Scholar
50	Adams JC: Fascin protrusions in cell interactions. Trends Cardiovasc Med. 14:221–226. 2004.PubMed/NCBI View Article : Google Scholar
51	Hashimoto Y, Ito T, Inoue H, Okumura T, Tanaka E, Tsunoda S, Higashiyama M, Watanabe G, Imamura M and Shimada Y: Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma. Clin Cancer Res. 11:2597–2605. 2005.PubMed/NCBI View Article : Google Scholar
52	Kabukcuoglu S, Onedr U, Ozalp SS, Dundar E, Yalcin OT and Colak E: Prognostic significance of fascin expression in endometrioid carcinoma. Eur J Gynaecol Oncol. 27:481–486. 2006.PubMed/NCBI
53	Xue LY, Hu N, Song YM, Zou SM, Shou JZ, Qian LX, Ren LQ, Lin DM, Tong T, He ZG, et al: Tissue microarray analysis reveals a tight correlation between protein expression pattern and progression of esophageal squamous cell carcinoma. BMC Cancer. 6(296)2006.PubMed/NCBI View Article : Google Scholar
54	Fu H, Hu Z, Wen J, Wang K and Liu Y: TGF-beta promotes invasion and metastasis of gastric cancer cells by increasing fascin1 expression via ERK and JNK signal pathways. Acta Biochim Biophys Sin (Shanghai). 41:648–656. 2009.PubMed/NCBI View Article : Google Scholar
55	Lu XF, Li EM, Du ZP, Xie JJ, Guo ZY, Gao SY, Liao LD, Shen ZY, Xie D and Xu LY: Specificity protein 1 regulates fascin expression in esophageal squamous cell carcinoma as the result of the epidermal growth factor/extracellular signal-regulated kinase signaling pathway activation. Cell Mol Life Sci. 67:3313–3329. 2010.PubMed/NCBI View Article : Google Scholar
56	Li A, Dawson JC, Forero-Vargas M, Spence HJ, Yu X, König I, Anderson K and Machesky LM: The actin-bundling protein fascin stabilizes actin in invadopodia and potentiates protrusive invasion. Curr Biol. 20:339–345. 2010.PubMed/NCBI View Article : Google Scholar
57	Van Audenhove I, Boucherie C, Pieters L, Zwaenepoel O, Vanloo B, Martens E, Verbrugge C, Hassanzadeh-Ghassabeh G, Vandekerckhove J, Cornelissen M, et al: Stratifying fascin and cortactin function in invadopodium formation using inhibitory nanobodies and targeted subcellular delocalization. FASEB J. 28:1805–1818. 2014.PubMed/NCBI View Article : Google Scholar
58	Li A, Morton JP, Ma Y, Karim SA, Zhou Y, Faller WJ, Woodham EF, Morris HT, Stevenson RP, Juin A, et al: Fascin is regulated by slug, promotes progression of pancreatic cancer in mice, and is associated with patient outcomes. Gastroenterology. 146:1386–1396.e1-e17. 2014.PubMed/NCBI View Article : Google Scholar
59	Jass JR: Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology. 50:113–130. 2007.PubMed/NCBI View Article : Google Scholar
60	Zhang JS, Li YC and Qi F: Expression of Twist and Fascin mRNA in colorectal carcinoma tissue. Shandong Med J. 27:42–43. 2015.(In Chinese).